Direkt zum Inhalt
Merck

In-vitro engineered human cerebral tissues mimic pathological circuit disturbances in 3D.

Communications biology (2022-03-25)
Aref Saberi, Albert P Aldenkamp, Nicholas A Kurniawan, Carlijn V C Bouten
ZUSAMMENFASSUNG

In-vitro modeling of brain network disorders such as epilepsy remains a major challenge. A critical step is to develop an experimental approach that enables recapitulation of in-vivo-like three-dimensional functional complexity while allowing local modulation of the neuronal networks. Here, by promoting matrix-supported active cell reaggregation, we engineered multiregional cerebral tissues with intact 3D neuronal networks and functional interconnectivity characteristic of brain networks. Furthermore, using a multi-chambered tissue-culture chip, we show that our separated but interconnected cerebral tissues can mimic neuropathological signatures such as the propagation of epileptiform discharges.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
CHIR99021, ≥98% (HPLC)
Sigma-Aldrich
Monoklonaler Anti-GFAP-Antikörper (Glial Fibrillary Acidic Protein, Saures Gliafaserprotein) in Maus hergestellte Antikörper, clone G-A-5, ascites fluid
Sigma-Aldrich
Anti-OLIG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Tubulin-Antikörper, Beta-III-Isoform, C-Terminus, Klon TU-20 (TUJ1 ähnlich), ascites fluid, clone TU-20 (Similar to TUJ1), Chemicon®
Sigma-Aldrich
Anti-vesikulärer-GABA-Transporter (vGAT)-Antikörper, Chemicon®, from rabbit
Sigma-Aldrich
Monoclonal Anti-VGLUT1 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL2754, purified immunoglobulin, buffered aqueous glycerol solution